Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

denk pharma gmbh & co. kg - glimepiride - tablets - 2mg

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - glimepiride, quantity: 2 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; povidone; indigo carmine; magnesium stearate; sodium starch glycollate; iron oxide yellow; lactose monohydrate - as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin dependent (type 2) diabetes mellitus.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sanofi belgium sa-nv - glimepiride 2 mg - tablet - 2 mg - glimepiride 2 mg - glimepiride

United States - English - NLM (National Library of Medicine)

stat rx usa llc - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 4 mg - glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (see dosage and administration ). glimepiride tablets are contraindicated in patients with - known hypersensitivity to the drug. - diabetic ketoacidosis, with or without coma. this condition should be treated with insulin.

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies ( 14.1)]. glimepiride tablets should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablet is contraindicated in patients with a history of a hypersensitivity reaction to: - glimepiride or any of the product’s ingredients [see warnings and precautions ( 5.2)]. sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives. reported hypersen

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride tablets usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies (14.1) ]. glimepiride tablets usp should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets are contraindicated in patients with a history of a hypersensitivity reaction to: sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives. reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serious reactions (e.g., anaphylaxis, angioedema, stevens-johnson syndrome, dyspnea) [see warnings and precautions (5.2) and adverse reactions (6.2) ]. pregnancy category c there are no adequate and well-controlled studies of

Australia - English - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - glimepiride, quantity: 2 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; sodium lauryl sulfate; sodium starch glycollate type a; povidone; microcrystalline cellulose; iron oxide yellow; indigo carmine aluminium lake - indicated as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 2 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

medis ehf - glimepiride - tablets - 2mg milligram

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies ( 14.1) ]. limitations of use glimepiride tablets should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets are contraindicated in patients with a history of a hypersensitivity reaction to:  - glimepiride or any of the product’s ingredients [see warnings and precautions ( 5.2) ]. - sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives.   risk summary available data from a small number of published studies and postmarketing experience with glimepiride use in pregnancy over decades have not identified any drug associated ri